Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
- Study Title
- Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
- Teva Identifier
- TVP-1012/PM103
- ClinicalTrials.gov Identifier
- NCT01049984
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: Rasagiline | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years and older
- Trial Duration
- 12/01/2009 - 10/01/2012
- Phase
- Phase 4
